Despite underwhelming results of anti-TNF in sepsis (44), the successful use in rheumatoid arthritis (RA) spurred trials in other chronic inflammatory diseases such as Crohn's disease, psoriasis and psoriatic arthritis (45). This evidence concerns the gene TNF and psoriasis.